Ehrlich Christopher B 4
4 · CERO THERAPEUTICS HOLDINGS, INC. · Filed Mar 27, 2024
Insider Transaction Report
Form 4
Ehrlich Christopher B
DirectorChairman and CEO
Transactions
- Award
Stock Option (Right to Buy)
2024-03-25+572,182→ 572,182 totalExercise: $1.77Exp: 2034-03-24→ Common Stock (572,182 underlying)
Footnotes (1)
- [F1]The shares underlying this option vest in forty-eight (48) monthly installments following the grant date, subject to the Reporting Person's continued service on each such vesting date.